Management of persistent anal canal carcinoma after combined-modality therapy: a clinical review

Anal canal carcinoma is a rare gastro-intestinal cancer. Radiochemotherapy is the recommended primary treatment for patients with non-metastatic carcinoma; surgery is generally reserved for persistent or recurrent disease. Follow-up and surveillance after primary treatment is paramount to classify p...

Descripción completa

Detalles Bibliográficos
Autores principales: Musio, Daniela, De Felice, Francesca, Raffetto, Nicola, Tombolini, Vincenzo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3996178/
https://www.ncbi.nlm.nih.gov/pubmed/24472223
http://dx.doi.org/10.1186/1748-717X-9-39

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3996178/
https://www.ncbi.nlm.nih.gov/pubmed/24472223
http://dx.doi.org/10.1186/1748-717X-9-39

Ejemplares similares